Investors

Filament Health is a leading exclusively natural psychedelic drug development company.

We are building a powerful platform to support the treatment of mental health conditions through FDA-approved psychedelic extracts from lab grown and regeneratively harvested plants produced by our wholly-owned subsidiary, Psilo Scientific.

Filament Health trades on the OTCQB Venture Market (OTCQB:FLHLF), Canada’s NEO Exchange (NEO:FH), and the Frankfurt Stock Exchange (FSE:7QS).

symbol
securityname
$
closeprice
lastupdatedate
lastupdatetime
FLHLF: OTCQBBid: 0.2253 Ask: 0.30
Source: OTC Markets Group | TermsReal-Time: 12:59:39 PM EST
Investor Events
Recent investor events offering insight into Filament’s business activities, clinical trials, and psychedelic drug development facility.
October Virtual CEO Q&A
August Virtual Investor Event
Corporate Presentation